Seeking Alpha

Mylan (MYL +0.9%) gets a boost today from an upgrade to Outperform at Leerink Swann, citing a...

Mylan (MYL +0.9%) gets a boost today from an upgrade to Outperform at Leerink Swann, citing a better outlook for EpiPen sales and optimism over the company's 2013 guidance. The firm ups its price target to $30 from $26.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|